GlassScriptPhysician profile
John F Gibbs
NPI 1063418176
$484.90
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.16 · 2020: $14.50 · 2022: $56.44 · 2023: $167 · 2024: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $163.93 | 2024 | Phasix Mesh |
| Abbott Laboratories | $55.56 | 2023-2024 | Freestyle Libre 3 |
| Amgen INC. | $48.19 | 2022-2023 | Evenity, Prolia |
| Corcept Therapeutics | $42.47 | 2023 | Korlym |
| Novo Nordisk INC | $30.50 | 2023-2024 | Sogroya |
| Ibsa Pharma INC. | $28.88 | 2022-2024 | Tirosint, Licart |
| Astellas Pharma US INC | $18.37 | 2024 | |
| Abbvie INC. | $15.49 | 2023 | |
| Merck Sharp & Dohme LLC | $14.50 | 2020 | |
| Embecta Corp. | $14.39 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Amneal Pharmaceuticals LLC | $14.34 | 2022 | |
| Smith+Nephew, INC. | $13.16 | 2019 | |
| Ethicon US, LLC | $12.93 | 2023 | Enseal |
| Mallinckrodt Hospital Products INC. | $12.19 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gibbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.